The Latest Breaking News from Alignment Healthcare

Alignment Healthcare shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 83.

Alignment Healthcare shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Throughout the last three months, 4 analysts have evaluated Alignment Healthcare (NASDAQ:ALHC), offering a diverse set of opinions from bullish to bearish.

The list of Medicare Advantage plan partnerships continues to grow with the latest offering from Kroger and Soda Health.

Over the past 3 months, 4 analysts have published their opinion on Alignment Healthcare (NASDAQ:ALHC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Upgrades

Analysts have provided the following ratings for Alignment Healthcare (NASDAQ:ALHC) within the last quarter:

Upgrades

Alignment Healthcare (NASDAQ:ALHC) brought in sales totaling $298.27 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 4.4%, resulting in a loss of $47.83 million.